🔎 Trials Near Me

Akèy › Kansè nan tete › Pennsylvania › Harrisburg

Etid klinik pou Kansè nan tete nan Harrisburg, PA

12 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Harrisburg (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Ap rekriteFaz 3
  • Univ of Pittsburg Med Ctr Pinnacle, Harrisburg
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT05827081

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Ap rekriteFaz 1/2
  • Penn State Milton S. Hershey Medical Center, Hershey · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06324357

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Penn State Milton S. Hershey Medical Center, Hershey · 12 mi lwen
  • Lehigh Valley Health Network - Cedar Crest, Allen · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Ap rekriteFaz 2
  • Penn State Cancer Institute, Hershey · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT04886531

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi lwen
  • Penn State Milton S Hershey Medical Center, Hershey · 12 mi lwen
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg · 8 mi lwen
  • Penn State Milton S Hershey Medical Center, Hershey · 12 mi lwen
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Penn State Milton S Hershey Medical Center, Hershey · 12 mi lwen
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

Ap rekriteFaz 1/2
  • Penn State Milton S Hershey Medical Center, Hershey · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05455619

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Ap rekriteFaz 4
  • Penn State Hershey Medical Center, Hershey · 12 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jan 22, 2026 · NCT04373564

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Ap rekriteEtid obsèvasyon
  • Penn State Health Medical Group - Andrews Patel, Harrisburg
  • Penn State Cancer Institute, Hershey · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06401421

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Ap rekriteFaz 3
  • Penn State Milton S Hershey Medical Center, Hershey · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961

Etid Kansè nan tete nan lòt vil

Lòt etid nan Harrisburg

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.